* PARTNERSHIP * BUSINESS OBJECTIVES * REGULATORY STRATEGY *
CE MARK * 510k * PMA * PROJECT MANAGEMENT * BUDGET * DOCUMENTATION *
STANDARDS * PRODUCT LIFE CYCLE * CONCEPT * IP * DESIGN & DEVELOPMENT *
DESIGN HISTORY FILE * MANUFACTURE * CONTROLLED ENVIRONMENT * GMP *
QMS * ISO 13485 * VERIFICATION * BIOMEDICAL SCIENCE * PRECLINICAL TESTING *
PROTOCOLS * BIOMATERIALS * PHYSICOCHEMISTRY * BIOLOGICAL EVALUATION *
ISO 10993 * GLP * TOXICOLOGICAL RISK ASSESSMENT * MECHANICAL TESTING *
PACKAGING * LABELLING * IFU * STERILISATION * STABILITY & SHELF LIFE *
REPORTS * VALIDATION * COMPETENT AUTHORITIES * NOTIFICATION * FDA *
CFR * IDE * CLINICAL EVALUATION * MDD * CLINICAL LITERATURE *
CLINICAL INVESTIGATION PLAN * ISO 14551 * INVESTIGATOR�S BROCHURE *
CLINICAL STUDY * DESIGN REVIEW * RISK MANAGEMENT * ISO 14971 *
TECHNICAL FILE * MASTER FILE * NOTIFIED BODY * LAUNCH * POST MARKET *
ALL CLINICAL DISCIPLINES * CROs * SUPPLIERS * PARTNERSHIP *
Medical Technology Regulatory Affairs Consultancy | |
| specialising in: |
|
contact Dr Sam Martin PhD
sam.martin@theregulatorypartnership.com
+44 (0) 7971 639052
website under construction